Compare LUCD & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUCD | AXR |
|---|---|---|
| Founded | 2018 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.4M | 127.3M |
| IPO Year | 2021 | N/A |
| Metric | LUCD | AXR |
|---|---|---|
| Price | $1.01 | $21.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $3.88 | N/A |
| AVG Volume (30 Days) | ★ 646.2K | 6.5K |
| Earning Date | 11-12-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 40.98 |
| EPS | N/A | ★ 2.48 |
| Revenue | $4,399,000.00 | ★ $48,454,000.00 |
| Revenue This Year | $13.30 | $28.57 |
| Revenue Next Year | $155.58 | N/A |
| P/E Ratio | ★ N/A | $8.82 |
| Revenue Growth | ★ 5.01 | N/A |
| 52 Week Low | $0.75 | $17.60 |
| 52 Week High | $1.80 | $39.68 |
| Indicator | LUCD | AXR |
|---|---|---|
| Relative Strength Index (RSI) | 38.39 | 48.49 |
| Support Level | $1.00 | $19.69 |
| Resistance Level | $1.10 | $22.55 |
| Average True Range (ATR) | 0.06 | 0.95 |
| MACD | -0.00 | 0.23 |
| Stochastic Oscillator | 7.20 | 64.09 |
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.